Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023
   PCE(x) 51.24-970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is 51.24 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202551.24
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 51.24
Positive
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹51.5 Cr 2.2% -28.5% -60.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,134.9 Cr 0.3% -12.1% -22.7% Stock Analytics
KIRI INDUSTRIES ₹2,189.3 Cr -0.2% -20% -47.7% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,496.6 Cr 7.5% -2.8% -36.8% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,033.8 Cr 10.7% 1% 5.8% Stock Analytics
BODAL CHEMICALS ₹683.6 Cr -1.3% 17.5% -17.3% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

2.2%

-28.5%

-60.6%

SENSEX

0.6%

-11.1%

-6.2%


You may also like the below Video Courses